A FSH-secreting pituitary adenoma discovered after ovarian hyperstimulation syndrome: a case report, illustrating pitfalls in the interpretation of serum FSH levels

被引:0
作者
Yano, Keigo [1 ]
Nakai, Go [1 ]
Matsutani, Hiroki [1 ]
Yamada, Takashi [2 ]
Ohmichi, Masahide [3 ]
Yamamoto, Kazuhiro [1 ]
Osuga, Keigo [1 ]
机构
[1] Osaka Med & Pharmaceut Univ, Dept Diagnost Radiol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
[2] Osaka Med & Pharmaceut Univ, Dept Pathol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
[3] Osaka Med & Pharmaceut Univ, Dept Obstet & Gynecol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
关键词
Magnetic resonance imaging; Ovarian hyperstimulation syndrome; OHSS; Pituitary adenoma; Case report; FOLLICLE-STIMULATING-HORMONE; WOMAN; PREGNANCY;
D O I
10.1186/s12905-024-03504-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Most cases of ovarian hyperstimulation syndrome (OHSS) are caused by infertility treatment using human menopausal gonadotropin (HMG) and human chorionic gonadotropin (hCG). OHSS is widely known to have a "spoke-wheel" appearance on imaging, presenting as bilateral symmetric enlargement of ovaries with multiple cysts of varying sizes. When this spoke-wheel appearance is observed in patients not undergoing infertility treatment, tumor-derived hormones such as follicle-stimulating hormone (FSH) and hCG should be measured. However, pitfalls exist in the interpretation of FSH levels. Case presentation A 29-year-old, gravida 0, para 0 woman visited her local doctor for irregular menstruation and to seek fertility treatment. At the first medical examination, bilateral ovarian tumors were found by ultrasonography, and she was referred to our hospital. Magnetic resonance imaging (MRI) findings of the bilateral ovarian tumors suggested typical OHSS, and thus levels of serum hormones including FSH and hCG were measured to determine whether endogenous follicle-stimulating hormones were the cause. Estradiol was elevated at 737 pg/ml (normal: 28.8-196.8 pg/ml in follicular phase) and luteinizing hormone (LH) was low at < 0.3 mIU/ml (normal: 1.4-15 in follicular phase, 2.1-88 mIU/ml in ovulatory phase). FSH (18.6 mIU/ml; normal: 3.0-14.7 in follicular phase, 4.5-22.5 mIU/ ml) and hCG (< 1.0 mIU/ml) were within normal ranges for non-pregnant women. Initially, since ovarian neoplasms producing estrogen were suspected, surgical resection was scheduled. However, computed tomography of the neck to pelvic region was performed to rule out metastatic ovarian tumors, and indicated a coincidental pituitary lesion, which was pathologically characterized as an FSH-secreting pituitary adenoma. Consequently, the final diagnosis was OHSS caused by an FSH-producing pituitary adenoma and the scheduled ovarian surgery was avoided. Conclusions Awareness of MRI findings of OHSS is important to avoid unnecessary invasive procedures. When treating patients who have suspected OHSS on imaging but whose serum FSH is in the normal range, it is also important to know that an unsuppressed FSH level despite the negative feedback effect of high estrogen should prompt investigation for a pituitary adenoma as a primary consideration.
引用
收藏
页数:6
相关论文
共 14 条
  • [1] Ovarian hyperstimulation secondary to ectopic secretion of follicle-stimulating hormone. Literature review prompted by a case
    Burgos, Jorge
    Cobos, Patricia
    Vidaurrazaga, Nerea
    Prieto, Begona
    Ocerin, Iratxe
    Matorras, Roberto
    [J]. FERTILITY AND STERILITY, 2009, 92 (03) : 1168.e5 - 1168.e8
  • [2] A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma
    Christin-Maitre, S
    Rongières-Bertrand, C
    Kottler, ML
    Lahlou, N
    Frydman, R
    Touraine, P
    Bouchard, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10) : 3450 - 3453
  • [3] Functional Gonadotroph Adenomas: Case Series and Report of Literature
    Cote, David J.
    Smith, Timothy R.
    Sandler, Courtney N.
    Gupta, Tina
    Bale, Tejus A.
    Bi, Wenya Linda
    Dunn, Ian F.
    De Girolami, Umberto
    Woodmansee, Whitney W.
    Kaiser, Ursula B.
    Laws, Edward R., Jr.
    [J]. NEUROSURGERY, 2016, 79 (06) : 823 - 831
  • [4] A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin-releasing hormone antagonist
    Garmes, Heraldo Mendes
    Grassiotto, Oswaldo Rocha
    Fernandes, Yvens Barbosa
    Queiroz, Luciano de Souza
    Vassalo, Jose
    de Oliveira, Daniel Minutti
    Benetti-Pinto, Cristina Laguna
    [J]. FERTILITY AND STERILITY, 2012, 97 (01) : 231 - 234
  • [5] Ilanchezhian Subramanian, 2015, Radiol Case Rep, V10, P1050, DOI 10.2484/rcr.v10i1.1050
  • [6] A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome
    Montanelli, L
    Delbaere, A
    Di Carlo, C
    Nappi, C
    Smits, G
    Vassart, G
    Costagliola, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) : 1255 - 1258
  • [7] Natural pregnancy in hypothyroid woman complicated by spontaneous ovarian hyperstimulation syndrome
    Nappi, RG
    Di Naro, E
    D'Aries, AP
    Nappi, L
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (03) : 610 - 611
  • [8] Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma
    Shimon, I
    Rubinek, T
    Bar-Hava, I
    Nass, D
    Hadani, M
    Amsterdam, A
    Harel, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) : 3635 - 3640
  • [9] Sicilia Vitaliano, 2006, Endocr Pract, V12, P417
  • [10] GONADOTROPH CELL ADENOMAS OF THE PITUITARY
    SNYDER, PJ
    [J]. ENDOCRINE REVIEWS, 1985, 6 (04) : 552 - 563